BHR Stock: Did This Luxury REIT Just Flip a New Switch?
Braemar Hotels & Resorts: Stub equity or governance play?
Two months ago I wrote this bear on BHR.
In that article, I argued Braemar was an oddity. Unlike most hotel REITs, it was not stock you held directly in the operating company. Instead you held a stub equity written on top of several luxury hotels.
Good assets. Bad structure.
Perched at the top were trophy assets like the Ritz- Carlton Reserve, Four Seasons, Park Hyatt and other luxury resorts. Wedged in the middle were layers of mortgage debt, preferred stock, transaction costs, and Ashford’s $480 million termination fee. Sprawled helplessly at the bottom was the common equity.
So the real issue was never “Are these hotels valuable?”
Instead, the question became “After the hotels are sold to private buyers, how much of that money actually gets distributed to common shareholders?”
That was my thesis in May. Good assets do not necessarily lead to a good stock. Between management and the shareholders is the capital stack, the contract stack, and an outsized management team with incentives completely divorced from shareholders.
Bennett’s tiny direct ownership of BHR common stock. Ashford-related parties were entitled to receive $480 million if BHR sold the hotels. Those two numbers alone illuminated a lot about the structure working against common shareholders.
Which is why my conclusion was “Wait.”
Yes BHR had cheap assets. But it was not a straightforward cheap asset story. This was equity reincarnated as a residual claim option. You could not assume the most bullish NAV and claim common shareholders would eventually receive that amount. Their stake was the final slice of a very long waterfall.
I still believe that framework is sound.
But the BHR ticker today is not the same security it was two months ago.
It’s not because the hotel portfolio suddenly improved. The hotels were great from day one.
The change involves who controls the company.
Old BHR was a sale waterfall obstructed by a massive termination fee.
New BHR looks like a governance play. A company that paid a hefty ransom but might actually survive free of the poison pill.
That is a very different security.
Before, the termination fee acted as a black hole parked in front of common shareholders. Before any sale proceeds could go to Berkshire Partners or Hillwood, before they could even hope to buy back stock or restart dividends, the first question was simple: “How much do we need to pay Ashford to let them leave?”
Now the $480 million fee still needs to be paid. But after it is paid, the external advisory agreement terminates. Bennett and the prior board members step aside. And suddenly BHR transforms from a something different into something else: a small-cap luxury hotel REIT with no obvious controlling shareholder, very few remaining assets, and a market capitalization of just $150 million or so.
That shift is the thesis.
The bullish case has flipped sides
The value argument for BHR is no longer “Look at these hotels!”
That story is too shallow. I covered it at length in May.
Instead let’s ask a different question: private-market buyers have already validated these assets. Is there a realistic scenario where the remaining “governance discount” can be resolved?
Park Hyatt Beaver Creek sold for $176 million. Sarasota, Hotel Yountville and Bardessono just sold for $437.5 million. Compared to where I thought the old model would price back in May, these are not firesale prices. They came in closer to the bullish end of my range.
That matters. A lot.
Suddenly we can cross off one side of an old binary: the value of BHR’s asset base is not purely theoretical. Real buyers are emerging who will pay low cap rates for these scarce luxury hotel assets. In other words, part of the bull case has been validated.
The private-market bid for trophy hotels is real.
The problem is private-market purchases do not hand free money to common shareholders.
All of those proceeds need to repay mortgage debt, extinguish mortgages, cover transaction costs, and flow down to the Ashford termination fee. Yes common shareholders see implicit asset value being unlocked. They do not however see that cash landing in their bank accounts.
It is why I am not writing a clean liquidation argument for BHR today.
I am also not writing about a normal REIT.
I am writing about a transition story.
For the next year or two, Braemar will operate like a de facto partial liquidation. Selling hotels, paying down debt, paying Ashford, and internalizing management.
Assuming no mistakes are made, investors should be left with a leaner, meaner REIT holding somewhere between six and eight luxury hotels.
How that equity gets valued in the future depends on one key question:
Will this new board want to return capital to shareholders?
Continuing operations can mean two very different things
Which is why the word “continuing” in continuing operations can actually have two totally opposite meanings.
Want BHR to return capital? Continuing operations does not mean standing pat. After buying back stock, cleaning up the capital structure, and lifting the poison pill, the new board could sell non-core hotels, initiate a common stock repurchase well below NAV, buy back preferred at discount, restart dividends, or even sell the whole company. In that scenario the market could begin pricing BHR stock closer to NAV. If you solve the governance structure there is now a credible path to distribute asset value to shareholders.
But what if you do nothing? What if continuing operations just means… well continuing operations?
Hotels continue to operate. These assets remain hard to replace. But common shareholders continue to own a tiny sliver of cash flow left over after debt interest, preferred dividends, corporate G&A, and “renovation reserves.”
That is not a trophy asset REIT. That is a low-multiple, no-dividend, governance impaired orphan REIT.
Same hotels. Different board. Completely different security.
The valuation framework
That’s the model I’m now working from for BHR:
Expected value per share ≈ (1 − q) × [ p × R + (1 − p) × F ] + L
Don’t overthink it.
p = probability of governance repair. Plain English translation: probability that a competent board emerges…or at least shareholder-friendly capital allocation. I would plug in something like 55%. That doesn’t mean Al Shams has a 55% chance of prevailing and winning everything. It’s a blend of possible outcomes: Al Shams wins, Al Shams settles for meaningful board seats, or the company’s own newly elected board is coerced into behaving-shareholder friendly by continued shareholder pressure.
R = value if door opens. I would plug in $4.0 to $4.5 per share. This is not assuming a door opens and BAM full liquidation happens today. It’s assuming the door opens and some process over time begins to unlock value: asset sales, buybacks, dividends, possible corporate sale, etc. Completed asset sales already signed and closed support this range.
F = value if door does not open. I would plug in $1.0 to $1.5 per share. Company continues to operate, but the cash never makes it to common shareholders. In that scenario, the common stock gets priced on thin distributable cash flow and a hefty governance discount.
q = deep, deep tail risk. I would plug in about 10%. Stuff like deal failure, hurricanes, refinancing stress, cash-bridge execution issues, etc. Some of that tail risk is less than it was in May (convertible notes gone, some debt extended, credible buyer quality on asset sales). But physical risk in the Caribbean and execution risk around the transition still loom large.
L = value of litigation option. I only give this $0.1 to $0.25 per share. Literally litigating for the $480 million termination fee gets you a headline number of greater than $6.50 per share. But legal odds are not great, and Maryland is not a favorable legal jurisdiction for this type of litigation. Litigation is better thought of as a proxy-fighting chip than as central to valuation.
Given those inputs, neutral expected value is around $2.7 to $2.8 per share.
With the stock trading around the low $2s, that’s definitely a positive expected value. Not “close your eyes, double your money” type of margin of safety, though.
And that is the important distinction.
Why NAV alone is not the answer
If you think about BHR as “static NAV is twice the stock price” you’re far too comfortable with your position. This is not a Graham-style net-net. Assets are big, but debt/preferred in front of common is also big. Common shareholders own the very rear of the capital structure. Percent changes in asset value get leveraged up and down by the capital structure.
The bullish case is not: “the assets back up and equal twice what we’re paying for the stock.”
The bullish case is: while the market is still pricing BHR stock as if Bennett-era governance/strategy was permanent, that structure is slowly being dismantled.
In the old thesis, the problem was $480 million termination fee coupled with Bennett/Ashford economics were completely misaligned with common shareholders.
In the new thesis, the problem is different: shareholders paid a very expensive ransom but the money-making machine that bleeds value away from common may finally be dismembered. Does the board that remains after the ransom is paid belong to shareholders?
Al Shams and the governance catalyst
That is where Al Shams comes in.
Al Shams doesn’t have to be perfect. They don’t even have to win every proposal outright. They just have to exist.
Without Al Shams, Company Narratives new “we have fixed the governance problem” story would be able to run unimpeded: “We have internalized management. We have refreshed the board. We have fixed the governance problem. Please give us time.”
With Al Shams, that statement has to survive a shareholder vote.
Fear of Al Shams also impacts how we think about the company selected new independent directors. I don’t believe they are all Bennett puppets. A better way to think about the company selected new independent directors is that they are reputation-maximizers. Compared to the old board they don’t have the same historical baggage. They don’t have the same Ashford fee stream. But they were selected through a process controlled by the old board and therefore face immediate legitimacy issues.
The quickest way for the new independent directors to solve that legitimacy problem is to prove to shareholders that Bennett’s replacement doesn’t just write lengthy public letters.
The best way to do that is through capital allocation.
If the first thing they do is buybacks, dividends, discounted preferred repurchases, truly review Ashford fees, or continue to sell non-core assets the market will start to believe there is a crack in the door.
If the first thing they do is build a new headquarters, set long term management incentives, or give speeches about creating a long term standalone platform BHR will trade back to orphan-REIT levels.
What BHR really is right now
So if you think about all of the above, BHR is not a hotel stock.
It is an event driven position on control, capital allocation, and time.
The May article covered the disease. Great assets wrapped in a bad stock.
This article is about how the disease may be progressing. This expensive external management buyout may have finally created a path for common shareholders to regain some value.
My takeaway:
BHR isn’t the “mathematically not cheap enough” stub equity that I wrote about back in May. Asset sale validation, outside mgmt. replacement, board refresh, and Al Shams pressure have created a positive-expected-value governance play.
That said, it is not a defensive value stock.
If the door does not open, shares are worth a bit north of $1.
If the door opens, shares are worth over $4.
Buying at today’s price, you are paying for the probability that the door opens.
Put differently: the central bet in BHR right now is not whether Dorado Beach is worth $500 million or $600 million. The central bet is whether the market is pricing BHR like a permanently discounted trophy- hotel shell that will continue to trade like an orphan-REIT forever.
Or whether the company is actually turning into a no controlling shareholder where management and the board are successfully pressured by activists to release asset value to shareholders.
Disclaimer: This article is for personal research and informational purposes only. It is not investment advice, nor is it a recommendation to buy or sell securities, or financial, legal, or tax advice. The valuation ranges, probabilities, and scenario analysis above are inherently subjective and may change rapidly as company filings, asset dispositions, market prices, legal proceedings, and governance events unfold. I may hold, buy or sell securities mentioned in this article at any time. Please do your own diligence and make decisions based on your own risk tolerance.